APA (7th ed.) Citation

LM, W., NY, S., NK, P., AM, F., JO, E., JS, D., . . . SQ, H. (2017). Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHD. Molecular therapy. Methods & clinical development, 8, 121. https://doi.org/10.1016/j.omtm.2017.12.005

Chicago Style (17th ed.) Citation

LM, Wallace, et al. "Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHD." Molecular Therapy. Methods & Clinical Development 8 (2017): 121. https://doi.org/10.1016/j.omtm.2017.12.005.

MLA (9th ed.) Citation

LM, Wallace, et al. "Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHD." Molecular Therapy. Methods & Clinical Development, vol. 8, 2017, p. 121, https://doi.org/10.1016/j.omtm.2017.12.005.